• Thu, November 10, 2022
Edward Tenthoff Maintained (ARWR) at Buy with Decreased Target to $64 on, Nov 10th, 2022
Edward Tenthoff of Piper Sandler, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy with Decreased Target from $72 to $64 on, Nov 10th, 2022.
Edward has made no other calls on ARWR in the last 4 months.
There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Galler of "Morgan Stanley" Initiated at Hold and Held Target at $41 on, Friday, September 9th, 2022
This is the rating of the analyst that currently disagrees with Edward
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $65 on, Monday, August 8th, 2022
Like: 👍
